Oxidative & nitrosative stress in depression: Why so much stress?

Neuroscience and Biobehavioral Reviews

Volumn 45, Issue , 2014, Pages 46-62

  Moylan, Steven ^a,g   Berk, Michael ^a,b,c,d,g   Dean, Olivia M ^a,b,d   Samuni, Yuval ^a   Williams, Lana J ^a,d   O'Neil, Adrienne ^a,c   Hayley, Amie C ^a   Pasco, Julie A ^a,d   Anderson, George ^e   Jacka, Felice N ^a   Maes, Michael ^a,f,h  

^a DEAKIN UNIVERSITY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Eccleston Square   (United Kingdom)

^f CHULALONGKORN UNIVERSITY   (Thailand)

^g BARWON HEALTH   (Australia)

^h STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Antioxidants; Autoimmune; Bipolar disorder; Depression; Inflammation; Oxidative nitrosative stress

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUTATHIONE PEROXIDASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VITAMIN D; CYSTINE; GLUTAMIC ACID; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN;

AMINO ACID METABOLISM; ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; DIETARY INTAKE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENVIRONMENTAL FACTOR; EXERCISE; GLUTAMATE CYSTINE CYCLE; GPX1 GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY BOWEL DISEASE; INOS GENE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MENTAL STRESS; METABOLIC SYNDROME X; MICROBIOME; MNSOD GENE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NITROSATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PON1 GENE; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; SMOKING; TRYPTOPHAN CATABOLITE PATHWAY; CATABOLISM; COMORBIDITY; GENETIC POLYMORPHISM; IMMUNOREACTIVITY; MAJOR DEPRESSION; MITOCHONDRIAL DYNAMICS; OBESITY; OXIDATION REDUCTION POTENTIAL; PSYCHOLOGICAL ASPECT; ANIMAL; DEPRESSIVE DISORDER; GENETICS; IMMUNOMODULATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DEPRESSIVE DISORDER; HUMANS; NEUROIMMUNOMODULATION; OXIDATIVE STRESS;

EID: 84901484896     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.05.007     Document Type: Review

References (264)

1. Adam-Vizi V., Starkov A.A. Calcium and mitochondrial reactive oxygen species generation: how to read the facts. J. Alzheimer's Dis. 2010, 20(Suppl. 2):S413-S426.
2. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:355-364.
3. Alberati-Giani D., Cesura A.M. Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators. Amino Acids 1998, 14:251-255.
4. Aleksandrovskii Iu A., Poiurovskii M.V., Neznamov G.G., Seredeniia S.B., Krasova E.A. Lipid peroxidation in emotional stress and neurotic disorders. Zh. Nevropatol. Psikhiatr. Im. S.S. Korsakova 1988, 88:95-101.
5. Alonso-Fernandez A., Garcia-Rio F., Arias M.A., Hernanz A., de la Pena M., Pierola J., Barcelo A., Lopez-Collazo E., Agusti A. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009, 64:581-586.
6. Anbarasi K., Vani G., Balakrishna K., Devi C.S. Effect of bacoside A on membrane-bound ATPases in the brain of rats exposed to cigarette smoke. J. Biochem. Mol. Toxicol. 2005, 19:59-65.
7. Anderson G., Maes M. Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol. Neurobiol. 2013, 14(2):771-783.
8. Anderson G., Maes M. Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications. Curr. Pharm. Des. 2014, 20:4126-4161.
9. Anderson G., Rodriguez M. Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. Eur. J. Neurol. 2011, 18:680-685.
10. Argacha J.F., Egrise D., Pochet S., Fontaine D., Lefort A., Libert F., Goldman S., van de Borne P., Berkenboom G., Moreno-Reyes R. Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression. J. Cardiovasc. Pharmacol. 2011, 58:65-71.
11. Arnardottir E.S., Mackiewicz M., Gislason T., Teff K.L., Pack A.I. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009, 32:447-470.
12. Arnardottir E.S., Maislin G., Schwab R.J., Staley B., Benediktsdottir B., Olafsson I., Juliusson S., Romer M., Gislason T., Pack A.I. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012, 35:921-932.
13. Atlantis E., Baker M. Obesity effects on depression: systematic review of epidemiological studies. Int. J. Obes. 2008, 32:881-891.
14. Atlantis E., Goldney R.D., Wittert G.A. Obesity and depression or anxiety. BMJ 2009, 339:b3868.
15. Autier P., Boniol M., Pizot C., Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014, 2(1):76-89.
16. Baune B.T., Dannlowski U., Domschke K., Janssen D.G., Jordan M.A., Ohrmann P., Bauer J., Biros E., Arolt V., Kugel H., Baxter A.G., Suslow T. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol. Psychiatry 2010, 67:543-549.
17. Berg R.D., Garlington A.W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect. Immun. 1979, 23:403-411.
18. Berk M., Jacka F. Preventive strategies in depression: gathering evidence for risk factors and potential interventions. Br. J. Psychiatry 2012, 201:339-341.
19. Berk M., Johansson S., Wray N.R., Williams L., Olsson C., Haavik J., Bjerkeset O. Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT. J. Affect. Disord. 2011, 131:207-213.
20. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., Yucel M., Gama C.S., Dodd S., Dean B., Magalhaes P.V., Amminger P., McGorry P., Malhi G.S. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 2011, 35:804-817.
21. Berk M., Plein H., Ferreira D. Platelet glutamate receptor supersensitivity in major depressive disorder. Clin. Neuropharmacol. 2001, 24:129-132.
22. Berk M., Wadee A.A., Kuschke R.H., O'Neill-Kerr A. Acute phase proteins in major depression. J. Psychosom. Res. 1997, 43:529-534.
23. Berk M., Williams L.J., Jacka F.N., O'Neil A., Pasco J.A., Moylan S., Allen N.B., Stuart A.L., Hayley A.C., Byrne M.L., Maes M. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med. 2013, 11:200.
24. Berry A., Cirulli F. The p66(Shc) gene paves the way for healthspan: evolutionary and mechanistic perspectives. Neurosci. Biobehav. Rev. 2013, 37:790-802.
25. Bhagwat S.V., Vijayasarathy C., Raza H., Mullick J., Avadhani N.G. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem. Pharmacol. 1998, 56:831-839.
26. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 2001, 64:43-51.
27. Blau S., Kohen R., Bass P., Rubinstein A. Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis. Dig. Dis. Sci. 2000, 45:1180-1187.
28. Bolling B.W., Chen C.Y., McKay D.L., Blumberg J.B. Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, Brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts. Nutr. Res. Rev. 2011, 24:244-275.
29. Bortolasci C.C., Vargas H.O., Souza-Nogueira A., Barbosa D.S., Moreira E.G., Nunes S.O., Berk M., Dodd S., Maes M. Lowered plasma paraoxonase (PON)1 activity is a traitmarker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J Affect Disord. 2014, 159:23-30. PubMed PMID: 24679385. 10.1016/j.jad.2014.02.018.
30. Bortolasci C.C., Vargas H.O., Souza-Nogueira A., Moreira E.G., Nunes S.O., Berk M., Dodd S., Barbosa D.S., Maes M. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity. Redox Rep. 2014, (in press).
31. Boullerne A.I., Rodriguez J.J., Touil T., Brochet B., Schmidt S., Abrous N.D., Le Moal M., Pua J.R., Jensen M.A., Mayo W., Arnason B.G., Petry K.G. Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neurosci. 2002, 22:123-132.
32. Braidy N., Grant R., Adams S., Brew B.J., Guillemin G.J. Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox. Res. 2009, 16:77-86.
33. Brasier A.R. The NF-kappaB regulatory network. Cardiovasc. Toxicol. 2006, 6:111-130.
34. Breslau N., Roth T., Rosenthal L., Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry 1996, 39:411-418.
35. Brocardo P.S., Assini F., Franco J.L., Pandolfo P., Muller Y.M., Takahashi R.N., Dafre A.L., Rodrigues A.L. Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain. Toxicol. Sci. 2007, 97:140-148.
36. Brown W.J., Ford J.H., Burton N.W., Marshall A.L., Dobson A.J. Prospective study of physical activity and depressive symptoms in middle-aged women. Am. J. Prev. Med. 2005, 29:265-272.
37. Bryan S., Baregzay B., Spicer D., Singal P.K., Khaper N. Redox-inflammatory synergy in the metabolic syndrome. Can. J. Physiol. Pharmacol. 2013, 91:22-30.
38. Bufalino C., Hepgul N., Aguglia E., Pariante C.M. The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav. Immun. 2013, 31:31-47.
39. Buysse D.J., Angst J., Gamma A., Ajdacic V., Eich D., Rossler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 2008, 31:473-480.
40. Carroll B.J. Dexamethasone suppression test in depression. Lancet 1980, 2:1249.
41. Carta S., Castellani P., Delfino L., Tassi S., Vene R., Rubartelli A. DAMPs and inflammatory processes: the role of redox in the different outcomes. J. Leukoc. Biol. 2009, 86:549-555.
42. Casado A., De Lucas N., Lopez-Fernandez E., Sanchez A., Jimenez J.A. Lipid peroxidation, occupational stress and aging in workers of a prehospital emergency service. Eur. J. Emerg. Med. 2006, 13:165-171.
43. Castagnoli K., Petzer J.B., Steyn S.J., van der Schyf C.J., Castagnoli N. Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration. Inflammopharmacology 2003, 11:183-188.
44. Ceprnja M., Derek L., Unic A., Blazev M., Fistonic M., Kozaric-Kovacic D., Franic M., Romic Z. Oxidative stress markers in patients with post-traumatic stress disorder. Coll. Antropol. 2011, 35:1155-1160.
45. Chan E.D., Riches D.W. IFN-gamma+LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am. J. Physiol. Cell Physiol. 2001, 280:C441-C450.
46. Chang P.P., Ford D.E., Mead L.A., Cooper-Patrick L., Klag M.J. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am. J. Epidemiol. 1997, 146:105-114.
47. Chavez A.M., Menconi M.J., Hodin R.A., Fink M.P. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit. Care Med. 1999, 27:2246-2251.
48. Che Y., Wang J.F., Shao L., Young T. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J. Psychiatry Neurosci. 2010, 35:296-302.
49. Check J., Byrd C.L., Menio J., Rippe R.A., Hines I.N., Wheeler M.D. Src kinase participates in LPS-induced activation of NADPH oxidase. Mol. Immunol. 2010, 47:756-762.
50. Christen S., Peterhans E., Stocker R. Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:2506-2510.
51. Clark E., Hoare C., Tanianis-Hughes J., Carlson G.L., Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005, 128:1258-1267.
52. D'Aquila P., Rose G., Panno M.L., Passarino G., Bellizzi D. SIRT3 gene expression: a link between inherited mitochondrial DNA variants and oxidative stress. Gene 2012, 497:323-329.
53. Dallas M., Boycott H.E., Atkinson L., Miller A., Boyle J.P., Pearson H.A., Peers C. Hypoxia suppresses glutamate transport in astrocytes. J. Neurosci. 2007, 27:3946-3955.
54. de Wit L., Luppino F., van Straten A., Penninx B., Zitman F., Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010, 178:230-235.
55. Debnath M., Berk M. Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications. Schizophr. Bull. 2014, 10.1093/schbul/sbu049.
56. Diani-Moore S., Ram P., Li X., Mondal P., Youn D.Y., Sauve A.A., Rifkind A.B. Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect. J. Biol. Chem. 2010, 285:38801-38810.
57. Dimopoulos N., Piperi C., Psarra V., Lea R.W., Kalofoutis A. Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression. Psychiatry Res. 2008, 161:59-66.
58. Djordjevic D.Z., Cubrilo D.G., Barudzic N.S., Vuletic M.S., Zivkovic V.I., Nesic M., Radovanovic D., Djuric D.M., Jakovljevic V. Comparison of blood pro/antioxidant levels before and after acute exercise in athletes and non-athletes. Gen. Physiol. Biophys. 2012, 31:211-219.
59. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
60. Dutcher J.P., Logan T., Gordon M., Sosman J., Weiss G., Margolin K., Plasse T., Mier J., Lotze M., Clark J., Atkins M. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study. Clin. Cancer Res. 2000, 6:3442-3450.
61. Dykens J.A., Sullivan S.G., Stern A. Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. Biochem. Pharmacol. 1987, 36:211-217.
62. El Kossi M.M., Zakhary M.M. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000, 31:1889-1892.
63. Eren I., Naziroglu M., Demirdas A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem. Res. 2007, 32:1188-1195.
64. Eren I., Naziroglu M., Demirdas A., Celik O., Uguz A.C., Altunbasak A., Ozmen I., Uz E. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem. Res. 2007, 32:497-505.
65. Evelson P., Gambino G., Travacio M., Jaita G., Verona J., Maroncelli C., Wikinski R., Llesuy S., Brites F. Higher antioxidant defences in plasma and low density lipoproteins from rugby players. Eur. J. Clin. Invest. 2002, 32:818-825.
66. Eyles D., Burne T., McGrath J. Vitamin D in fetal brain development. Semin. Cell Dev. Biol. 2011, 22:629-636.
67. Eyre H., Baune B.T. Neuroimmunological effects of physical exercise in depression. Brain Behav. Immun. 2012, 26:251-266.
68. Fisher-Wellman K., Bloomer R.J. Acute exercise and oxidative stress: a 30 year history. Dynam. Med. 2009, 8:1.
69. Forlenza M.J., Miller G.E. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom. Med. 2006, 68:1-7.
70. Foster G.E., Poulin M.J., Hanly P.J. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp. Physiol. 2007, 92:51-65.
71. Fransson M., Adner M., Uddman R., Cardell L.O. Lipopolysaccharide-induced down-regulation of uteroglobin in the human nose. Acta Otolaryngol. (Stockh.) 2007, 127:285-291.
72. Funakoshi H., Kanai M., Nakamura T. Modulation of tryptophan metabolism, pomotion of neurogenesis and alteration of anxiety-related behavior in tryptophan 2, 3-dioxygenase-deficient mice. Int. J. Tryptophan Res. 2011, 4:7.
73. Funato Y., Miki H. Redox regulation of Wnt signalling via nucleoredoxin. Free Radic. Res. 2010, 44:379-388.
74. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114:1752-1761.
75. Galecki P., Galecka E., Maes M., Chamielec M., Orzechowska A., Bobinska K., Lewinski A., Szemraj J. The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J. Affect. Disord. 2012, 138:360-366.
76. Galecki P., Maes M., Florkowski A., Lewinski A., Galecka E., Bienkiewicz M., Szemraj J. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J. Affect. Disord. 2011, 129:175-182.
77. Galecki P., Smigielski J., Florkowski A., Bobinska K., Pietras T., Szemraj J. Analysis of two polymorphisms of the manganese superoxide dismutase gene (Ile-58Thr and Ala-9Val) in patients with recurrent depressive disorder. Psychiatry Res. 2010, 179:43-46.
78. Galecki P., Szemraj J., Bienkiewicz M., Florkowski A., Galecka E. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol. Rep. 2009, 61:436-447.
79. Galimov E.R., Chernyak B.V., Sidorenko A.S., Tereshkova A.V., Chumakov P.M. Prooxidant properties of p66shc are mediated by mitochondria in human cells. PLoS ONE 2014, 9:e86521.
80. Galitovskiy V., Qian J., Chernyavsky A.I., Marchenko S., Gindi V., Edwards R.A., Grando S.A. Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J. Immunol. 2011, 187:2677-2687.
81. Garate I., Garcia-Bueno B., Madrigal J.L., Caso J.R., Alou L., Gomez-Lus M.L., Mico J.A., Leza J.C. Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol. Psychiatry 2013, 73:32-43.
82. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 2002, 13:100-105.
83. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:730-743.
84. George N., Kumar T.P., Antony S., Jayanarayanan S., Paulose C.S. Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. Br. J. Nutr. 2012, 108:1410-1418.
85. Ghanizadeh A., Berk M. Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia. Med. Gas Res. 2013, 3:11.
86. Goda K., Hamane Y., Kishimoto R., Ogishi Y. Radical scavenging properties of tryptophan metabolites. Estimation of their radical reactivity. Adv. Exp. Med. Biol. 1999, 467:397-402.
87. Goldstein L.E., Leopold M.C., Huang X., Atwood C.S., Saunders A.J., Hartshorn M., Lim J.T., Faget K.Y., Muffat J.A., Scarpa R.C., Chylack L.T., Bowden E.F., Tanzi R.E., Bush A.I. 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 2000, 39:7266-7275.
88. Gomes E.C., Silva A.N., de Oliveira M.R. Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species. Oxid. Med. Cell. Longevity 2012, 2012:756132.
89. Gradinaru D., Borsa C., Ionescu C., Margina D., Prada G.I., Jansen E. Vitamin D status and oxidative stress markers in the elderly with impaired fasting glucose and type 2 diabetes mellitus. Aging Clin. Exp. Res. 2012, 24:595-602.
90. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
91. Guidetti P., Schwarcz R. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur. J. Neurosci. 1999, 11:3857-3863.
92. Gulec M., Ozkol H., Selvi Y., Tuluce Y., Aydin A., Besiroglu L., Ozdemir P.G. Oxidative stress in patients with primary insomnia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 37:247-251.
93. Gustafson B., Gogg S., Hedjazifar S., Jenndahl L., Hammarstedt A., Smith U. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E999-E1003.
94. Haddad J.J. Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. Cytokines Cell. Mol. Ther. 2000, 6:177-187.
95. Halaris A., Meresh E., Fareed J., Hoppensteadt D., Kimmons S., Sinacore J. 2. Tumor necrosis factor alpha as a biomarker in major depressive disorder. Brain Behav. Immun. 2012, 26(Suppl. 1):S1.
96. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M.J., Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J. Clin. Endocrinol. Metab. 2004, 89:4963-4971.
97. Harris M., Glozier N., Ratnavadivel R., Grunstein R.R. Obstructive sleep apnea and depression. Sleep Med. Rev. 2009, 13:437-444.
98. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
99. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
100. Hvas A.M., Juul S., Bech P., Nexo E. Vitamin B6 level is associated with symptoms of depression. Psychother. Psychosom. 2004, 73:340-343.
101. Irie M., Asami S., Nagata S., Miyata M., Kasai H. Relationships between perceived workload, stress and oxidative DNA damage. Int. Arch. Occup. Environ. Health 2001, 74:153-157.
102. Jacka F.N., Maes M., Pasco J.A., Williams L.J., Berk M. Nutrient intakes and the common mental disorders in women. J. Affect. Disord. 2012, 141:79-85.
103. Jacka F.N., Pasco J.A., Williams L.J., Leslie E.R., Dodd S., Nicholson G.C., Kotowicz M.A., Berk M. Lower levels of physical activity in childhood associated with adult depression. J. Sci. Med. Sport 2010, 14:222-226.
104. Jatuporn S., Sangwatanaroj S., Saengsiri A.O., Rattanapruks S., Srimahachota S., Uthayachalerm W., Kuanoon W., Panpakdee O., Tangkijvanich P., Tosukhowong P. Short-term effects of an intensive lifestyle modification program on lipid peroxidation and antioxidant systems in patients with coronary artery disease. Clin. Hemorheol. Microcirc. 2003, 29:429-436.
105. Jelic S., Padeletti M., Kawut S.M., Higgins C., Canfield S.M., Onat D., Colombo P.C., Basner R.C., Factor P., LeJemtel T.H. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008, 117:2270-2278.
106. Jequier E. Leptin signaling, adiposity, and energy balance. Ann. N.Y. Acad. Sci. 2002, 967:379-388.
107. Johnson L.A., Phillips J.A., Mauer C., Edwards M., Balldin V.H., Hall J.R., Barber R., Conger T.L., Ho E.J., O'Bryant S.E. The impact of GPX1 on the association of groundwater selenium and depression: a Project FRONTIER study. BMC Psychiatry 2013, 13:7.
108. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., McEwen J.J., Bickford P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci. 1999, 19:8114-8121.
109. Kaczmarek A., Vandenabeele P., Krysko D.V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38:209-223.
110. Kennedy D.O., Veasey R., Watson A., Dodd F., Jones E., Maggini S., Haskell C.F. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology (Berl.) 2010, 211:55-68.
111. Kern P.A., Saghizadeh M., Ong J.M., Bosch R.J., Deem R., Simsolo R.B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 1995, 95:2111-2119.
112. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 2003, 8:365-370.
113. Kjaergaard M., Waterloo K., Wang C.E., Almas B., Figenschau Y., Hutchinson M.S., Svartberg J., Jorde R. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br. J. Psychiatry 2012, 201:360-368.
114. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:744-759.
115. Lai J., Moxey A., Nowak G., Vashum K., Bailey K., McEvoy M. The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. J. Affect. Disord. 2012, 136:e31-e39.
116. Lansdowne A.T., Provost S.C. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl.) 1998, 135:319-323.
117. Lazarou C., Kapsou M. The role of folic acid in prevention and treatment of depression: an overview of existing evidence and implications for practice. Complement. Ther. Clin. Pract. 2010, 16:161-166.
118. LeBlanc M., Merette C., Savard J., Ivers H., Baillargeon L., Morin C.M. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009, 32:1027-1037.
119. Lee H., Lee Y.J., Choi H., Ko E.H., Kim J.W. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem. 2009, 284:10601-10609.
120. Lee P.H., Perlis R.H., Jung J.Y., Byrne E.M., Rueckert E., Siburian R., Haddad S., Mayerfeld C.E., Heath A.C., Pergadia M.L., Madden P.A., Boomsma D.I., Penninx B.W., Sklar P., Martin N.G., Wray N.R., Purcell S.M., Smoller J.W. Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder. Transl. Psychiatry 2012, 2:e184.
121. Lee S.Y., Lee S.J., Han C., Patkar A.A., Masand P.S., Pae C.U. Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 46:224-235.
122. Lee Y.J., Choi B., Lee E.H., Choi K.S., Sohn S. Immobilization stress induces cell death through production of reactive oxygen species in the mouse cerebral cortex. Neurosci. Lett. 2006, 392:27-31.
123. Leipnitz G., Schumacher C., Dalcin K.B., Scussiato K., Solano A., Funchal C., Dutra-Filho C.S., Wyse A.T., Wannmacher C.M., Latini A., Wajner M. In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochem. Int. 2007, 50:83-94.
124. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 2001, 52:159-164.
125. Leo R., Di Lorenzo G., Tesauro M., Cola C., Fortuna E., Zanasi M., Troisi A., Siracusano A., Lauro R., Romeo F. Decreased plasma adiponectin concentration in major depression. Neurosci. Lett. 2006, 407:211-213.
126. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36:764-785.
127. Linneberg A., Nielsen N.H., Madsen F., Frolund L., Dirksen A., Jorgensen T. Factors related to allergic sensitization to aeroallergens in a cross-sectional study in adults: The Copenhagen Allergy Study. Clin. Exp. Allergy 2001, 31:1409-1417.
128. Liu J., Somera-Molina K.C., Hudson R.L., Dubocovich M.L. Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus. J. Pineal Res. 2013, 54:222-231.
129. Lobato K.R., Cardoso C.C., Binfare R.W., Budni J., Wagner C.L., Brocardo P.S., de Souza L.F., Brocardo C., Flesch S., Freitas A.E., Dafre A.L., Rodrigues A.L. Alpha-tocopherol administration produces an antidepressant-like effect in predictive animal models of depression. Behav. Brain Res. 2010, 209:249-259.
130. Logue M.W., Baldwin C., Guffanti G., Melista E., Wolf E.J., Reardon A.F., Uddin M., Wildman D., Galea S., Koenen K.C., Miller M.W. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol. Psychiatry 2013, 18:937-942.
131. Lotze M.T., Zeh H.J., Rubartelli A., Sparvero L.J., Amoscato A.A., Washburn N.R., Devera M.E., Liang X., Tor M., Billiar T. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 2007, 220:60-81.
132. Luberto C.M., White C., Sears R.W., Cotton S. Integrative medicine for treating depression: an update on the latest evidence. Curr. Psychiatry Rep. 2013, 15:391.
133. Lucas K., Maes M. Role of the Toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol. Neurobiol. 2013, 48:190-204.
134. Luchese C., Pinton S., Nogueira C.W. Brain and lungs of rats are differently affected by cigarette smoke exposure: antioxidant effect of an organoselenium compound. Pharmacol. Res. 2009, 59:194-201.
135. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., Zitman F.G. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010, 67:220-229.
136. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., Meltzer H.Y. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999, 85:275-291.
137. Maes M., D'Haese P.C., Scharpe S., D'Hondt P., Cosyns P., De Broe M.E. Hypozincemia in depression. J. Affect. Disord. 1994, 31:135-140.
138. Maes M., De Vos N., Pioli R., Demedts P., Wauters A., Neels H., Christophe A. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J. Affect. Disord. 2000, 58:241-246.
139. Maes M., Delange J., Ranjan R., Meltzer H.Y., Desnyder R., Cooremans W., Scharpe S. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 1997, 66:1-11.
140. Maes M., Fisar Z., Medina M., Scapagnini G., Nowak G., Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 2012, 20:127-150.
141. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:676-692.
142. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol. Lett. 2008, 29:117-124.
143. Maes M., Kubera M., Leunis J.C., Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 2012, 141:55-62.
144. Maes M., Kubera M., Leunis J.C., Berk M., Geffard M., Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr. Scand. 2013, 127:344-354.
145. Maes M., Kubera M., Mihaylova I., Geffard M., Galecki P., Leunis J.C., Berk M. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. J. Affect. Disord. 2013, 149:23-29.
146. Maes M., Kubera M., Obuchowiczwa E., Goehler L., Brzeszcz J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuroendocrinol. Lett. 2011, 32:7-24.
147. Maes M., Leonard B.E., Myint A.M., Kubera M., Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:702-721.
148. Maes M., Meltzer H.Y., Scharpe S., Bosmans E., Suy E., De Meester I., Calabrese J., Cosyns P. Relationships between lower plasma l-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res. 1993, 49:151-165.
149. Maes M., Mihaylova I., Kubera M., Leunis J.C. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS. Neuroendocrinol. Lett. 2008, 29:313-319.
150. Maes M., Mihaylova I., Kubera M., Leunis J.C., Geffard M. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J. Affect. Disord. 2011, 135:414-418.
151. Maes M., Mihaylova I., Leunis J.C. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuroendocrinol. Lett. 2007, 28:861-867.
152. Maes M., Ruckoanich P., Chang Y.S., Mahanonda N., Berk M. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:769-783.
153. Maes M., Vandoolaeghe E., Neels H., Demedts P., Wauters A., Meltzer H.Y., Altamura C., Desnyder R. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol. Psychiatry 1997, 42:349-358.
154. Manda K., Bhatia A.L. Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol. Toxicol. 2003, 19:367-372.
155. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
156. Martinsson L., Wei Y., Xu D., Melas P.A., Mathe A.A., Schalling M., Lavebratt C., Backlund L. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres. Transl. Psychiatry 2013, 3:e261.
157. Mather A.S., Rodriguez C., Guthrie M.F., McHarg A.M., Reid I.C., McMurdo M.E. Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: randomised controlled trial. Br. J. Psychiatry 2002, 180:411-415.
158. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 2011, 12:453-466.
159. McCall W.V., Harding D., O'Donovan C. Correlates of depressive symptoms in patients with obstructive sleep apnea. J. Clin. Sleep Med. 2006, 2:424-426.
160. McLoughlin I.J., Hodge J.S. Zinc in depressive disorder. Acta Psychiatr. Scand. 1990, 82:451-453.
161. Metin G., Atukeren P., Alturfan A.A., Gulyasar T., Kaya M., Gumustas M.K. Lipid peroxidation, erythrocyte superoxide-dismutase activity and trace metals in young male footballers. Yonsei Med. J. 2003, 44:979-986.
162. Miller M.W., Wolf E.J., Logue M.W., Baldwin C.T. The retinoid-related orphan receptor alpha (RORA) gene and fear-related psychopathology. J. Affect. Disord. 2013, 151:702-708.
163. Millman R.P., Fogel B.S., McNamara M.E., Carlisle C.C. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J. Clin. Psychiatry 1989, 50:348-351.
164. Moretti M., Colla A., de Oliveira Balen G., dos Santos D.B., Budni J., de Freitas A.E., Farina M., Severo Rodrigues A.L. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J. Psychiatr. Res. 2012, 46:331-340.
165. Morimoto K., Morikawa M., Kimura H., Ishii N., Takamata A., Hara Y., Uji M., Yoshida K. Mental stress induces sustained elevation of blood pressure and lipid peroxidation in postmenopausal women. Life Sci. 2008, 82:99-107.
166. Morris G., Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab. Brain Dis. 2014, 29(1):19-36.
167. Morrison C.D., Pistell P.J., Ingram D.K., Johnson W.D., Liu Y., Fernandez-Kim S.O., White C.L., Purpera M.N., Uranga R.M., Bruce-Keller A.J., Keller J.N. High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling. J. Neurochem. 2010, 114:1581-1589.
168. Moylan S., Eyre H.A., Maes M., Baune B.T., Jacka F.N., Berk M. Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neurosci. Biobehav. Rev. 2013, 37:573-584.
169. Moylan S., Jacka F.N., Pasco J.A., Berk M. Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med. 2012, 10:123.
170. Moylan S., Jacka F.N., Pasco J.A., Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain Behav. 2013, 3:302-326.
171. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 2013, 18:595-606.
172. Murakami K., Haneda M., Yoshino M. Prooxidant action of xanthurenic acid and quinoline compounds: role of transition metals in the generation of reactive oxygen species and enhanced formation of 8-hydroxy-2'-deoxyguanosine in DNA. Biometals 2006, 19:429-435.
173. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2:1547-1558.
174. Nair-Shalliker V., Armstrong B.K., Fenech M. Does vitamin D protect against DNA damage?. Mutat. Res. 2012, 733:50-57.
175. Nanri A., Hayabuchi H., Ohta M., Sato M., Mishima N., Mizoue T. Serum folate and depressive symptoms among Japanese men and women: a cross-sectional and prospective study. Psychiatry Res. 2012, 200:349-353.
176. Neckelmann D., Mykletun A., Dahl A.A. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007, 30:873-880.
177. Newman M.B., Arendash G.W., Shytle R.D., Bickford P.C., Tighe T., Sanberg P.R. Nicotine's oxidative and antioxidant properties in CNS. Life Sci. 2002, 71:2807-2820.
178. Niu K., Guo H., Kakizaki M., Cui Y., Ohmori-Matsuda K., Guan L., Hozawa A., Kuriyama S., Tsuboya T., Ohrui T., Furukawa K., Arai H., Tsuji I., Nagatomi R. A tomato-rich diet is related to depressive symptoms among an elderly population aged 70 years and over: a population-based, cross-sectional analysis. J. Affect. Disord. 2013, 144:165-170.
179. Nowson C.A., McGrath J.J., Ebeling P.R., Haikerwal A., Daly R.M., Sanders K.M., Seibel M.J., Mason R.S. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med. J. Aust. 2012, 196:686-687. Working Group of: A., New Zealand, B., Mineral Society, E.S.o.A., Osteoporosis, A.
180. Okuda S., Nishiyama N., Saito H., Katsuki H. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J. Neurochem. 1998, 70:299-307.
181. Opitz C.A., Litzenburger U.M., Sahm F., Ott M., Tritschler I., Trump S., Schumacher T., Jestaedt L., Schrenk D., Weller M., Jugold M., Guillemin G.J., Miller C.L., Lutz C., Radlwimmer B., Lehmann I., von Deimling A., Wick W., Platten M. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011, 478:197-203.
182. Organisation W.H. World Health Report 2002, World Health Organistion Press, Switzerland.
183. Owen A.J., Batterham M.J., Probst Y.C., Grenyer B.F., Tapsell L.C. Low plasma vitamin E levels in major depression: diet or disease?. Eur. J. Clin. Nutr. 2005, 59:304-306.
184. Ozkan Y., Firat H., Simsek B., Torun M., Yardim-Akaydin S. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath. 2008, 12:149-154.
185. Pan A., Sun Q., Czernichow S., Kivimaki M., Okereke O.I., Lucas M., Manson J.E., Ascherio A., Hu F.B. Bidirectional association between depression and obesity in middle-aged and older women. Int. J. Obes. 2012, 36:595-602.
186. Parletta N., Milte C.M., Meyer B.J. Nutritional modulation of cognitive function and mental health. J. Nutr. Biochem. 2013, 24:725-743.
187. Pasco J.A., Henry M.J., Nicholson G.C., Sanders K.M., Kotowicz M.A. Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med. J. Aust. 2001, 175:401-405.
188. Pasco J.A., Jacka F.N., Williams L.J., Evans-Cleverdon M., Brennan S.L., Kotowicz M.A., Nicholson G.C., Ball M.J., Berk M. Dietary selenium and major depression: a nested case-control study. Complement. Ther. Med. 2012, 20:119-123.
189. Pasco J.A., Jacka F.N., Williams L.J., Henry M.J., Nicholson G.C., Kotowicz M.A., Berk M. Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study. J. Affect. Disord. 2008, 107:221-225.
190. Pasco J.A., Nicholson G.C., Williams L.J., Jacka F.N., Henry M.J., Kotowicz M.A., Schneider H.G., Leonard B.E., Berk M. Association of high-sensitivity C-reactive protein with de novo major depression. Br. J. Psychiatry 2010, 197:372-377.
191. Pasco J.A., Williams L.J., Jacka F.N., Brennan S.L., Berk M. Obesity and the relationship with positive and negative affect. Aust. N.Z. J. Psychiatry 2013, 47:477-482.
192. Pasco J.A., Williams L.J., Jacka F.N., Henry M.J., Coulson C.E., Brennan S.L., Leslie E., Nicholson G.C., Kotowicz M.A., Berk M. Habitual physical activity and the risk for depressive and anxiety disorders among older men and women. Int. Psychogeriatr. 2011, 23:292-298.
193. Pasco J.A., Williams L.J., Jacka F.N., Ng F., Henry M.J., Nicholson G.C., Kotowicz M.A., Berk M. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br. J. Psychiatry 2008, 193:322-326.
194. Pathak L., Agrawal Y., Dhir A. Natural polyphenols in the management of major depression. Expert Opin. Invest. Drugs 2013, 22:863-880.
195. Peet M., Murphy B., Shay J., Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 1998, 43:315-319.
196. Peng T., Lu X., Feng Q. NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes. FASEB J. 2005, 19:293-295.
197. Perlis M.L., Giles D.E., Buysse D.J., Tu X., Kupfer D.J. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J. Affect. Disord. 1997, 42:209-212.
198. Pertsov S.S., Balashova T.S., Kubatieva A.A., Sosnovskii A.S., Pirogova G.V., Abramov V.M. Lipid peroxidation and antioxidant enzymes in rat brain in acute emotional stress: effect of interleukin-1beta. Biulleten' eksperimental'noi biologii i meditsiny 1995, 120:244-247.
199. Phillips A.C., Robertson T., Carroll D., Der G., Shiels P.G., McGlynn L., Benzeval M. Do symptoms of depression predict telomere length? Evidence from the west of Scotland twenty-07 study. Psychosom. Med. 2013, 75:288-296.
200. Quan Z.F., Yang C., Li N., Li J.S. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J. Gastroenterol. 2004, 10:1992-1994.
201. Quik M., Perez X.A., Bordia T. Nicotine as a potential neuroprotective agent for Parkinson's disease. Mov. Disord. 2012, 27:947-957.
202. Reiter R.J., Paredes S.D., Manchester L.C., Tan D.X. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit. Rev. Biochem. Mol. Biol. 2009, 44:175-200.
203. Reiter R.J., Tan D.X., Manchester L.C., Pilar Terron M., Flores L.J., Koppisepi S. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv. Med. Sci. 2007, 52:11-28.
204. Ren S., Correia M.A. Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase?. Arch. Biochem. Biophys. 2000, 377:195-203.
205. Rief W., Pilger F., Ihle D., Bosmans E., Egyed B., Maes M. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res. 2001, 105:165-174.
206. Rimer J., Dwan K., Lawlor D.A., Greig C.A., McMurdo M., Morley W., Mead G.E. Exercise for depression. Cochrane Database Syst. Rev. 2012, 7:CD004366.
207. Rios C., Santamaria A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem. Res. 1991, 16:1139-1143.
208. Rubartelli A., Lotze M.T. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007, 28:429-436.
209. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 2004, 68:975-981.
210. Sagatun A., Sogaard A.J., Bjertness E., Selmer R., Heyerdahl S. The association between weekly hours of physical activity and mental health: a three-year follow-up study of 15-16-year-old students in the city of Oslo, Norway. BMC Public Health 2007, 7:155.
211. Sanacora G., Rothman D.L., Mason G., Krystal J.H. Clinical studies implementing glutamate neurotransmission in mood disorders. Ann. N.Y. Acad. Sci. 2003, 1003:292-308.
212. Sanchez-Villegas A., Martinez-Gonzalez M.A., Estruch R., Salas-Salvado J., Corella D., Covas M.I., Aros F., Romaguera D., Gomez-Gracia E., Lapetra J., Pinto X., Martinez J.A., Lamuela-Raventos R.M., Ros E., Gea A., Warnberg J., Serra-Majem L. Mediterranean dietary pattern and depression: the PREDIMED randomized trial. BMC Med. 2013, 11:208.
213. Sanders K.M., Stuart A.L., Williamson E.J., Jacka F.N., Dodd S., Nicholson G., Berk M. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br. J. Psychiatry 2011, 198:357-364.
214. Sankhla M., Sharma T.K., Mathur K., Rathor J.S., Butolia V., Gadhok A.K., Vardey S.K., Sinha M., Kaushik G.G. Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. Clin. Lab. 2012, 58:385-392.
215. Santamaria A., Galvan-Arzate S., Lisy V., Ali S.F., Duhart H.M., Osorio-Rico L., Rios C., St'astny F. Quinolinic acid induces oxidative stress in rat brain synaptosomes. Neuroreport 2001, 12:871-874.
216. Scapagnini G., Davinelli S., Drago F., De Lorenzo A., Oriani G. Antioxidants as antidepressants: fact or fiction?. CNS Drugs 2012, 26:477-490.
217. Schroder C.M., O'Hara R. Depression and obstructive sleep apnea (OSA). Ann. Gen. Psychiatry 2005, 4:13.
218. Schubert D., Piasecki D. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 2001, 21:7455-7462.
219. Shalev I., Moffitt T.E., Braithwaite A.W., Danese A., Fleming N.I., Goldman-Mellor S., Harrington H.L., Houts R.M., Israel S., Poulton R., Robertson S.P., Sugden K., Williams B., Caspi A. Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder. Mol. Psychiatry 2014.
220. Sivonova M., Zitnanova I., Hlincikova L., Skodacek I., Trebaticka J., Durackova Z. Oxidative stress in university students during examinations. Stress 2004, 7:183-188.
221. Skarupski K.A., Tangney C., Li H., Ouyang B., Evans D.A., Morris M.C. Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am. J. Clin. Nutr. 2010, 92:330-335.
222. Smith A.J., Smith R.A., Stone T.W. 5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones. Neurotox. Res. 2009, 15:303-310.
223. Solin M.S., Ball M.J., Robertson I., de Silva A., Pasco J.A., Kotowicz M.A., Nicholson G.C., Collier G.R. Relationship of serum leptin to total and truncal body fat. Clin. Sci. 1997, 93:581-584.
224. Song C., Lin A., Bonaccorso S., Heide C., Verkerk R., Kenis G., Bosmans E., Scharpe S., Whelan A., Cosyns P., de Jongh R., Maes M. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J. Affect. Disord. 1998, 49:211-219.
225. Sosnovskii A.S., Kozlov A.V. Increased lipid peroxidation in the rat hypothalamus after short-term emotional stress. Biulleten' eksperimental'noi biologii i meditsiny 1992, 113:486-488.
226. Sperner-Unterweger B., Kohl C., Fuchs D. Immune changes and neurotransmitters: possible interactions in depression?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 48:268-276.
227. Stangherlin E.C., Luchese C., Ardais A.P., Nogueira C.W. Passive smoke exposure induces oxidative damage in brains of rat pups: protective role of diphenyl diselenide. Inhal. Toxicol. 2009, 21:868-874.
228. Stedman R.L. The chemical composition of tobacco and tobacco smoke. Chem. Rev. 1968, 68:153-207.
229. Strawbridge W.J., Deleger S., Roberts R.E., Kaplan G.A. Physical activity reduces the risk of subsequent depression for older adults. Am. J. Epidemiol. 2002, 156:328-334.
230. Szewczyk B., Kubera M., Nowak G. The role of zinc in neurodegenerative inflammatory pathways in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:693-701.
231. Taylor D.J., Lichstein K.L., Durrence H.H., Reidel B.W., Bush A.J. Epidemiology of insomnia, depression, and anxiety. Sleep 2005, 28:1457-1464.
232. Taylor M.J., Carney S.M., Goodwin G.M., Geddes J.R. Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J. Psychopharmacol. (Oxf.) 2004, 18:251-256.
233. Teychenne M., Ball K., Salmon J. Physical activity and likelihood of depression in adults: a review. Prev. Med. 2008, 46:397-411.
234. Thome G.R., Spanevello R.M., Mazzanti A., Fiorenza A.M., Duarte M.M., da Luz S.C., Pereira M.E., Morsch V.M., Schetinger M.R., Mazzanti C.M. Vitamin E decreased the activity of acetylcholinesterase and level of lipid peroxidation in brain of rats exposed to aged and diluted sidestream smoke. Nicotine Tobacco Res. 2011, 13:1210-1219.
235. Todar K. Todar's Online Textbook of Bacteriology 2006, University of Wisconsin-Madison Department of Bacteriology.
236. Tolmunen T., Hintikka J., Ruusunen A., Voutilainen S., Tanskanen A., Valkonen V.P., Viinamaki H., Kaplan G.A., Salonen J.T. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother. Psychosom. 2004, 73:334-339.
237. Tsuboi H., Tatsumi A., Yamamoto K., Kobayashi F., Shimoi K., Kinae N. Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J. Affect. Disord. 2006, 91:63-70.
238. Tsukamoto H., Fukudome K., Takao S., Tsuneyoshi N., Kimoto M. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. Int. Immunol. 2010, 22:271-280.
239. Tsuno N., Besset A., Ritchie K. Sleep and depression. J. Clin. psychiatry 2005, 66:1254-1269.
240. Tuon T., Valvassori S.S., Lopes-Borges J., Fries G.R., Silva L.A., Kapczinski F., Quevedo J., Pinho R.A. Effects of moderate exercise on cigarette smoke exposure-induced hippocampal oxidative stress values and neurological behaviors in mice. Neurosci. Lett. 2010, 475:16-19.
241. Tyagi E., Agrawal R., Nath C., Shukla R. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain. Eur. J. Pharmacol. 2010, 640:206-210.
242. Uchida K. Redox-derived damage-associated molecular patterns: ligand function of lipid peroxidation adducts. Redox Biol. 2013, 1:94-96.
243. Uher R., Perroud N., Ng M.Y., Hauser J., Henigsberg N., Maier W., Mors O., Placentino A., Rietschel M., Souery D., Zagar T., Czerski P.M., Jerman B., Larsen E.R., Schulze T.G., Zobel A., Cohen-Woods S., Pirlo K., Butler A.W., Muglia P., Barnes M.R., Lathrop M., Farmer A., Breen G., Aitchison K.J., Craig I., Lewis C.M., McGuffin P. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am. J. Psychiatry 2010, 167:555-564.
244. Van Hunsel F., Wauters A., Vandoolaeghe E., Neels H., Demedts P., Maes M. Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments. Psychiatry Res. 1996, 65:159-169.
245. Vargas H.O., Nunes S.O., Pizzo de Castro M., Cristina Bortolasci C., Sabbatini Barbosa D., Kaminami Morimoto H., Venugopal K., Dodd S., Maes M., Berk M. Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J. Affect. Disord. 2013, 150:923-930.
246. Volna J., Kemlink D., Kalousova M., Vavrova J., Majerova V., Mestek O., Svarcova J., Sonka K., Zima T. Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med. Sci. Monitor 2011, 17:CR491-CR497.
247. Wang C., Wu H.M., Jing X.R., Meng Q., Liu B., Zhang H., Gao G.D. Oxidative parameters in the rat brain of chronic mild stress model for depression: relation to anhedonia-like responses. J. Membr. Biol. 2012, 245:675-681.
248. Wang D.W., Zhou R.B., Yao Y.M., Zhu X.M., Yin Y.M., Zhao G.J., Dong N., Sheng Z.Y. Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. J. Pharmacol. Exp. Therapeut. 2010, 335:553-561.
249. Werner E.R., Werner-Felmayer G. Substrate and cofactor requirements of indoleamine 2,3-dioxygenase in interferon-gamma-treated cells: utilization of oxygen rather than superoxide. Curr. Drug Metab. 2007, 8:201-203.
250. Wiest R. Bacterial translocation. Biosci. Microflora 2005, 24:61-90.
251. Wiest R., Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005, 41:422-433.
252. Williams C.M., El Mohsen M.A., Vauzour D., Rendeiro C., Butler L.T., Ellis J.A., Whiteman M., Spencer J.P. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic. Biol. Med. 2008, 45:295-305.
253. Wilson C.B., McLaughlin L.D., Nair A., Ebenezer P.J., Dange R., Francis J. Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS ONE 2013, 8:e76146.
254. Wolkowitz O.M., Mellon S.H., Epel E.S., Lin J., Dhabhar F.S., Su Y., Reus V.I., Rosser R., Burke H.M., Kupferman E., Compagnone M., Nelson J.C., Blackburn E.H. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress - preliminary findings. PLoS ONE 2011, 6:e17837.
255. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21:1457-1467.
256. Wu A., Ying Z., Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur. J. Neurosci. 2004, 19:1699-1707.
257. Wu C.C., Chang J.H., Chen C.C., Su S.B., Yang L.K., Ma W.Y., Zheng C.M., Diang L.K., Lu K.C. Calcitriol treatment attenuates inflammation and oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Tohoku J. Exp. Med. 2011, 223:153-159.
258. Yager S., Forlenza M.J., Miller G.E. Depression and oxidative damage to lipids. Psychoneuroendocrinology 2010, 35:1356-1362.
259. Yang R., Han X., Uchiyama T., Watkins S.K., Yaguchi A., Delude R.L., Fink M.P. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. 2003, 285:G621-G629.
260. Yildiz D., Ercal N., Armstrong D.W. Nicotine enantiomers and oxidative stress. Toxicology 1998, 130:155-165.
261. Yu T., Robotham J.L., Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2653-2658.
262. Zameer A., Hoffman S.A. Immunoglobulin binding to brain in autoimmune mice. J. Neuroimmunol. 2001, 120:10-18.
263. Zhou Y.P., Jiang Z.M., Sun Y.H., Wang X.R., Ma E.L., Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. J. Parenteral Enteral Nutr. 2003, 27:241-245.
264. Zhu W.L., Shi H.S., Wei Y.M., Wang S.J., Sun C.Y., Ding Z.B., Lu L. Green tea polyphenols produce antidepressant-like effects in adult mice. Pharmacol. Res. 2012, 65:74-80.